{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:47:27Z","timestamp":1761511647830},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[1999,7,9]],"date-time":"1999-07-09T00:00:00Z","timestamp":931478400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[1999,8]]},"DOI":"10.1038\/sj.bjc.6690599","type":"journal-article","created":{"date-parts":[[2002,9,5]],"date-time":"2002-09-05T18:08:00Z","timestamp":1031249280000},"page":"1792-1796","source":"Crossref","is-referenced-by-count":42,"title":["Concurrent conventionally factionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-small-cell lung carcinoma"],"prefix":"10.1038","volume":"80","author":[{"given":"M I","family":"Koukourakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Bahlitzanakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Froudarakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Giatromanolaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Georgoulias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Koumiotaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Christodoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Kyrias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Skarlatos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Kostantelos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Beroukas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[1999,7,9]]},"reference":[{"key":"BF6690599_CR1","unstructured":"Beham, M., Vogel, M., McDonnell, J., Farkas, S. t., Furst, A. & Jauch, K. W. (1998). Apoptosis after genotoxic damage is enhanced by Taxol-induced phosphorylation of bcl-2 and correlates with nuclear import of p53. Proc Am Assoc Cancer Res 39: 463 (abstract no. 3151)"},{"key":"BF6690599_CR2","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/0959-8049(96)00212-2","volume":"32A","author":"O Brodin","year":"1996","unstructured":"Brodin, O., Nou, E., Mercke, C., Lind\u00e9n, C. J., Lundstr\u00f6m, R., Arwidi, A., Brink, J. & Ringborg, U. (1996). Comparison of induction chemotherapy before radiotherapy with radiotherapy only in patients with locally advanced squamous cell carcinoma of the lung. The Swedish Lung Cancer Study Group. Eur J Cancer 32A: 1893\u20131900.","journal-title":"Eur J Cancer"},{"key":"BF6690599_CR3","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/bjc.1994.311","volume":"70","author":"T Cerny","year":"1994","unstructured":"Cerny, T., Kaplan, S., Pavlidis, N., Sch\u00f6ffski, P., Epelbaum, R., van Meerbeek, J., Wanders, J., Franklin, H. R. & Kaye, S. (1994). Docetaxel (taxotere @) is active in non-small cell lung cancer: a phase II trial of EORTC Early Clinical Trials Group (ECTG). Br J Cancer 70: 384\u2013387.","journal-title":"Br J Cancer"},{"key":"BF6690599_CR4","first-page":"1513","volume":"31","author":"JT Chaffey","year":"1971","unstructured":"Chaffey, J. T. & Hellman, S. (1971). Differing responses to radiation of murin bone marrow stem cells in relation to the cell cycle. Cancer Res 31: 1513\u20131516.","journal-title":"Cancer Res"},{"key":"BF6690599_CR5","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/0360-3016(92)90382-R","volume":"24","author":"H Choy","year":"1992","unstructured":"Choy, H., Rodriguez, F., Koester, S., Hilsenbeck, S. & Von Hoff, D. D. (1992). Synergistic effects of Taxol\/Taxotere on radiation sensitivity on human tumor cell. Int J Radiat Oncol Biol Phys 24: 274\u2013275 (abstract no. 1059).","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF6690599_CR6","doi-asserted-by":"publisher","first-page":"14940","DOI":"10.1056\/NEJM199010043231403","volume":"323","author":"RO Dillman","year":"1990","unstructured":"Dillman, R. O., Seagren, S. L., Propert, K. J., Guerra, J., Eaton, W. L., Perry, M. C., Carey, R. W., Frei, EF III & Green, M. R. (1990). A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 323: 14940\u201314945.","journal-title":"N Engl J Med"},{"key":"BF6690599_CR7","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1200\/JCO.1994.12.6.1238","volume":"12","author":"FV Fossella","year":"1994","unstructured":"Fossella, F. V., Lee, J. S., Murphy, W. K., Lipman, S. M., Calayag, M., Pang, A., Chasen, M., Shin, D. M., Glisson, B., Benner, S., Huber, M., Perez-Soler, R., Hong, W. K. & Rober, M. (1994). Phase II study of docetaxel for recurrent or metastatic non-small cell lung cancer. J Clin Oncol 12: 1238\u20131244.","journal-title":"J Clin Oncol"},{"key":"BF6690599_CR8","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1200\/JCO.1994.12.11.2301","volume":"12","author":"P Francis","year":"1994","unstructured":"Francis, P., Schneider, J., Hann, L., Bolmeceda, C., Barakat, R., Phillips, M. & Hakes, T. (1994). Phase II trial of docetaxel in patients with platinum-refractory advanced ovarian cancer. J Clin Oncol 12: 2301\u20132308.","journal-title":"J Clin Oncol"},{"key":"BF6690599_CR9","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1021\/jm00107a017","volume":"34","author":"F Geuritte-Voegelein","year":"1996","unstructured":"Geuritte-Voegelein, F., Guenard, D., Lavelle, F., Le Goff, M., Mangatal, L. & Pottier, P. (1996). Relationships between the structure of Taxol analogues and their antimitotic activity. J Med Chem 34: 992\u2013998.","journal-title":"J Med Chem"},{"key":"BF6690599_CR10","first-page":"1253","volume":"56","author":"S Haldar","year":"1996","unstructured":"Haldar, S., Chintapalli, J. & Croce, C. M. (1996). Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res 56: 1253\u20131255.","journal-title":"Cancer Res"},{"key":"BF6690599_CR11","unstructured":"Hermanek, P. & Sobin, J. (1992). UICC TNM Classification of Malignant Tumours, 4th ed. Springer-Verlag: Berlin"},{"key":"BF6690599_CR12","unstructured":"Koukourakis, M. (1998). The use of ethyol in chemotherapy and radiation therapy. In Cytoprotection in Cancer Therapy: Improving the Therapeutic Index of Cancer Treatment. Ethyol Investigators Meeting, May 1998, Los Angeles, California, USA"},{"key":"BF6690599_CR13","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3109\/02841869509094018","volume":"34","author":"M Koukourakis","year":"1995","unstructured":"Koukourakis, M., Skarlatos, J., Kosma, L., Giatromanolaki, A. & Yannakakis, D. (1995). Radiotherapy alone for non-small cell lung carcinoma. Five year disease-free survival and patterns of failure. Acta Oncol 34: 525\u2013530.","journal-title":"Acta Oncol"},{"key":"BF6690599_CR14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0360-3016(95)02102-7","volume":"34","author":"M Koukourakis","year":"1996","unstructured":"Koukourakis, M., Hlouverakis, G., Kosma, L., Skarlatos, J., Damilakis, J., Giatromanolaki, A. & Yonnakakis, D. (1996). The impact of overall treatment time on the results of radiotherapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys 34: 315\u2013322.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF6690599_CR15","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/S0959-8049(97)10101-0","volume":"34","author":"M Koukourakis","year":"1998","unstructured":"Koukourakis, M., Kourousis, C., Kamilaki, M., Koukouraki, S., Giatromanolaki, A., Kakolyris, S., Kotsakis, A., Androulakis, N., Bahlitzanakis, N. & Georgoulias, V. (1998). Weekly Docetaxel and Concomitant Boost Radiotherapy for Non-Small-Cell Lung Cancer. A Phase I\/II Dose Escalation Trial. Eur J Cancer 34: 838\u2013844.","journal-title":"Eur J Cancer"},{"key":"BF6690599_CR16","volume-title":"Am J Clin Oncol","author":"M Koukourakis","year":"1998","unstructured":"Koukourakis, M., Stefanaki, E., Giatromanolaki, A., Armenaki, A., Fragiadaki, C., Georgoulias, V., Koumandakis, E., Kranidis, A. & Helidonis, E. (1998). Fractionated carboplatin radiosensitization. A phase I dose escalation study. Am J Clin Oncol 1999 (in press)"},{"key":"BF6690599_CR17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1093\/jnci\/84.1.58","volume":"84","author":"T Le Chevalier","year":"1992","unstructured":"Le Chevalier, T., Arriagada, R., Tarayre, M., Lacombe-Terrier, M. J., Laplanche, A., Quoix, E., Ruffie, P., Martin, M. & Douillard, J. Y. (1992). Significant effect of adjuvant chemotherapy on survival in locally advanced non-small-cell lung carcinoma. J Natl Cancer Inst 84: 58","journal-title":"J Natl Cancer Inst"},{"key":"BF6690599_CR18","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0277-5379(98)90020-7","volume":"24","author":"K Mattson","year":"1998","unstructured":"Mattson, K., Holsti, L. R., Holsti, P., Jakobsson, M., Kajanti, M., Liippo, K., M\u00e4ntyl\u00e4, M., Niitamo-Korhonen, S., Nikkanen, V. & Nordman, E. (1998). Inoperable non-small cell lung cancer: radiation with or without chemotherapy. Eur J Cancer Clin Oncol 24: 477\u2013482.","journal-title":"Eur J Cancer Clin Oncol"},{"key":"BF6690599_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1200\/JCO.1998.16.1.159","volume":"16","author":"AM Mauers","year":"1998","unstructured":"Mauers, A. M., Masters, G., Haraf, D., Hoffman, P. C., Watson, S. M., Golomb, H. M. & Vokes, E. E. (1998). Phase I study of docetaxel with concommitant thoracic radiotherapy. J Clin Oncol 16: 159\u2013164.","journal-title":"J Clin Oncol"},{"key":"BF6690599_CR20","doi-asserted-by":"publisher","first-page":"681","DOI":"10.7326\/0003-4819-115-9-681","volume":"115","author":"RF Morton","year":"1991","unstructured":"Morton, R. F., Jett, J. R., McGinnis, W. L., Earle, J. D., Therneau, T. M., Krook, J. E., Elliott, T. E., Mailliard, J. A., Nelimark, R. A. & Maksymiuk, A. W. et al (1991). Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial. Ann Intern Med 115: 681\u2013686.","journal-title":"Ann Intern Med"},{"key":"BF6690599_CR21","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/jnci\/83.4.288","volume":"83","author":"I Ringel","year":"1991","unstructured":"Ringel, I. & Horwitz, S. B. (1991). Studies with RP-56976 (Taxotere): a semi-synthetic analogue of Taxol. J Natl Cancer Inst 83: 288\u2013291.","journal-title":"J Natl Cancer Inst"},{"key":"BF6690599_CR22","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1056\/NEJM199202203260805","volume":"326","author":"C Shaake-Koning","year":"1992","unstructured":"Shaake-Koning, C., van-den-Bogaert, W., Dalesio, O., Festen, J., Hoogenhout, J., van Houtte, P., Kirkpatrick, A., Koolen, M., Maat, B. & Nijs, A. (1992). Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N Engl J Med 326: 524\u2013530.","journal-title":"N Engl J Med"},{"key":"BF6690599_CR23","doi-asserted-by":"crossref","unstructured":"Throuvalas, N., Antonadou, D., Pulizzi, M. & Sarris, G. (1995). Evaluation of the efficacy and safety of GM-CSF in the prophylaxis of mucositis in patients with head and neck cancer treated by RT. In Proceedings of ECCO 1995, pp. 593. Federation of European Cancer Societies: Paris (abstract 431)","DOI":"10.1016\/0959-8049(95)95684-X"},{"key":"BF6690599_CR24","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1200\/JCO.1994.12.7.1458","volume":"12","author":"E Tomiak","year":"1994","unstructured":"Tomiak, E., Piccart, M. J., Kerger, S., Lips, S., Awada, A., de Valeriola, D., Lossignol, D., Sculier, J. P., Auzannet, V., Le Bail, N., Bayssas, M. & Klastersky, J. (1994). Phase I study of docetaxel administered as 1-hour intravenous infusion on a weekly basis. J Clin Oncol 12: 1458\u20131467.","journal-title":"J Clin Oncol"},{"key":"BF6690599_CR25","unstructured":"World Health Organization (1979). Handbook for Reporting Results of Cancer Treatment. WHO Offset Publications: Geneva"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6690599.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6690599","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6690599.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:54:48Z","timestamp":1684414488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6690599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,7,9]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1999,8]]}},"alternative-id":["BF6690599"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6690599","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,7,9]]}}}